Literature DB >> 7554629

Morselized allograft in acetabular reconstruction. A postmortem retrieval analysis.

R D Heekin1, C A Engh, T Vinh.   

Abstract

Contained acetabular defects often are repaired at revision surgery using morselized bone allograft. The extent to which this graft becomes incorporated is unknown, and the value of radiographs for predicting allograft incorporation is unclear. To better understand the effectiveness of morselized allograft in revision hip arthroplasty, the authors studied postmortem specimens from 3 patients treated with this type of graft. Histologic analysis of acetabular components in situ for 18 months showed allograft fragments invested with loose myxofibrous tissue. Vascularized tissue had penetrated the allograft fragments to a depth of 4 mm. In peripheral areas, the vascularized ingrowth was accompanied by partial osteoclastic resorption of graft trabeculae and application of living bone to allograft fragments. After 53 months in situ, graft fragments had remodeled and showed progressive vascular ingrowth. By 83 months, the graft almost completely had incorporated. Morselized allograft bone is useful for restoring bone deficiency within contained acetabular defects. The graft does incorporate, but the extent of graft incorporation cannot be predicted accurately by postoperative radiographs.

Entities:  

Mesh:

Year:  1995        PMID: 7554629

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  12 in total

1.  Revision hip arthroplasty using impacted cancellous bone and cement: a long-term follow-up study.

Authors:  Gowthaman Arumugam; Shashi Kumar Nanjayan; Conal Quah; Philip Wraighte; Peter Howard
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-09-23

2.  The combined effect of parathyroid hormone and bone graft on implant fixation.

Authors:  H Daugaard; B Elmengaard; T T Andreassen; J Baas; J E Bechtold; K Soballe
Journal:  J Bone Joint Surg Br       Date:  2011-01

Review 3.  Uncemented Cups and Impaction Bone Grafting for Acetabular Bone Loss in Revision Hip Arthroplasty: A Review of Rationale, Indications, and Outcomes.

Authors:  Rocco D'Apolito; Luigi Zagra
Journal:  Materials (Basel)       Date:  2022-05-23       Impact factor: 3.748

4.  Good results with cemented total hip arthroplasty in patients between 40 and 50 years of age.

Authors:  Daniël C J de Kam; Jean W M Gardeniers; René P H Veth; B Willem Schreurs
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

5.  Assessment of the metabolic activity of bone grafts with (18)F-fluoride PET.

Authors:  Winfried Brenner; Cheryl Vernon; Ernest U Conrad; Janet F Eary
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-10       Impact factor: 9.236

6.  THA revisions using impaction allografting with mesh is durable for medial but not lateral acetabular defects.

Authors:  Eduardo García-Rey; Rosario Madero; Eduardo García-Cimbrelo
Journal:  Clin Orthop Relat Res       Date:  2015-12       Impact factor: 4.176

7.  The Exeter method-acetabular impaction grafting with cemented reimplantation.

Authors:  T G Petheram; J R Howell
Journal:  Oper Orthop Traumatol       Date:  2014-04-02       Impact factor: 1.154

8.  Reconstruction of the acetabulum in THA using femoral head autografts in developmental dysplasia of the hip.

Authors:  Markus D Schofer; Thomas Pressel; Jan Schmitt; Thomas J Heyse; Ulrich Boudriot
Journal:  J Orthop Surg Res       Date:  2011-06-22       Impact factor: 2.359

9.  The use of morselized allografts without impaction and cemented cage support in acetabular revision surgery: a 4- to 9-year follow-up.

Authors:  Huifeng Ding; Yuanqing Mao; Bin Yu; Zhenan Zhu; Huiwu Li; Baoqing Yu; Jianming Huang
Journal:  J Orthop Surg Res       Date:  2015-05-23       Impact factor: 2.359

10.  Multiple Acetabular Revisions in THA - Poor Outcome Despite Maximum Effort.

Authors:  O Bischel; J B Seeger; Jb Seeger; M Krüger; M Krüge; R G Bitsch; Bg Bitsch
Journal:  Open Orthop J       Date:  2012-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.